Spotlight Case Study 2: Design & Development of Peptide Conjugate Antiviral Therapeutics

10:02 am - Tuesday 28th April 2026

Speakers:

Barbara HIbner
Cso
Decoy Therapeutics
Michael Lipp
Chief Technology Officer & Co-Founder
Decoy Therapeutics